We serve Chemical Name:5-ethyl-2-methyl-4-phenylpyrazol-3-amine CAS:890014-40-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-ethyl-2-methyl-4-phenylpyrazol-3-amine
CAS.NO:890014-40-1
Synonyms:3-Ethyl-1-methyl-4-phenyl-1H-pyrazol-5-amine
Molecular Formula:C12H15N3
Molecular Weight:201.26800
HS Code:2933199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:373ºC at 760 mmHg
Density:1.12g/cm3
Index of Refraction:1.599
PSA:43.84000
Exact Mass:201.12700
LogP:2.81290
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Ethyl-1-methyl-4-phenyl-1H-pyrazol-5-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Ethyl-1-methyl-4-phenyl-1H-pyrazol-5-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Ethyl-1-methyl-4-phenyl-1H-pyrazol-5-amine Use and application,3-Ethyl-1-methyl-4-phenyl-1H-pyrazol-5-amine technical grade,usp/ep/jp grade.
Related News: China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug. 5-ethyl-2-methyl-4-phenylpyrazol-3-amine manufacturer Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday. 5-ethyl-2-methyl-4-phenylpyrazol-3-amine supplier China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug. 5-ethyl-2-methyl-4-phenylpyrazol-3-amine vendor South Korea and Japan are barring noncitizens who traveled recently to Hubei, the province at the center of the outbreak. 5-ethyl-2-methyl-4-phenylpyrazol-3-amine factory China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.
